Literature DB >> 3257204

Suppression of cytotoxic responses by a supernatant factor derived from Mycoplasma hyorhinis-infected mammalian cell lines.

H S Teh1, M Ho, L D Williams.   

Abstract

A class of interleukin-2-dependent T-cell clones, isolated from a murine fetal thymus, was previously shown to suppress the induction of cytotoxic responses to alloantigens (H.-S. Teh, M. Ho, and W. R. McMaster, J. Immunol. 135:1582-1588, 1985). In that article, the immunosuppressive properties of these T-cell clones were shown to be a direct consequence of infection by Mycoplasma hyorhinis. Suppression of cytotoxic responses was mediated by both the mycoplasmas and a 200-kilodalton factor present in supernatants of infected cultures. This factor was sensitive to proteases but was resistant to heating to 60 degrees C for 1 h and to incubation on ice at pH 2 or pH 14 for 4 h. The production of suppressor factor in infected cultures was independent of the viability or the protein synthesis capability of the mammalian cells, suggesting that it was produced by M. hyorhinis. The factor was most suppressive when it was added during the early stages of the cytotoxic response. Its suppressive effects on cytotoxic responses were not reversed by the addition of an excess of recombinant interleukin-2. This factor also suppressed mitogenic responses to lipopolysaccharide. However, it is not a growth inhibitor since it did not affect the proliferation of tumor cell lines. A simple method for detecting M. hyorhinis in the infected T-cell clones and for eliminating it is described.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257204      PMCID: PMC259256          DOI: 10.1128/iai.56.1.197-203.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Possible mechanism for Mycoplasma inhibition of lymphocyte transformation induced by phytohaemagglutinin.

Authors:  M F Barile; B G Leventhal
Journal:  Nature       Date:  1968-08-17       Impact factor: 49.962

2.  Utilization of T cell hybridomas to establish that a soluble factor derived from Mycoplasma arthritidis is truly a genetically restricted polyclonal T cell activator.

Authors:  R L Yowell; B C Cole; R A Daynes
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

3.  A mutant human T-cell line producing immunosuppressive factor(s).

Authors:  C Y Lau; S Budz-Tymkewycz; E Y Wang; A Ishaque
Journal:  Cell Immunol       Date:  1984-08       Impact factor: 4.868

4.  Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues.

Authors:  A Wang; S D Lu; D F Mark
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

5.  Isolation and characterization of novel suppressor T cell clones from murine fetal thymus.

Authors:  H S Teh; M Ho; W R McMaster
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

6.  Purification of mouse interleukin 2 to apparent homogeneity.

Authors:  D Riendeau; D G Harnish; R C Bleackley; V Paetkau
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

7.  A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.

Authors:  J J Proust; M A Buchholz; A A Nordin
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

8.  Procedures for the purification of interleukin 3 to homogeneity.

Authors:  J N Ihle; J Keller; L Henderson; F Klein; E Palaszynski
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

9.  Mechanism of action of a suppressor-activating factor (SAF) produced by a human T cell line.

Authors:  C Y Lau; E Y Wang; D Li; S Budz-Tymkewycz; V Visconti; A Ishaque
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

10.  Studies of PPLO infection. V. Inhibition of lymphocyte mitosis and antibody formation by mycoplasmal extracts.

Authors:  M S Simberkoff; G J Thorbecke; L Thomas
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives.

Authors:  Ali Dawood; Samah Attia Algharib; Gang Zhao; Tingting Zhu; Mingpu Qi; Kong Delai; Zhiyu Hao; Marawan A Marawan; Ihsanullah Shirani; Aizhen Guo
Journal:  Front Cell Infect Microbiol       Date:  2022-05-13       Impact factor: 6.073

2.  Mycoplasma hyorhinis molecules that induce tumor necrosis factor alpha secretion by human monocytes.

Authors:  D A Kostyal; G H Butler; D H Beezhold
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

Review 3.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

4.  Mycoplasma fermentans-derived high-molecular-weight material induces interleukin-6 release in cultures of murine macrophages and human monocytes.

Authors:  H Quentmeier; E Schmitt; H Kirchhoff; W Grote; P F Mühlradt
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

Review 5.  Inflammation-inducing Factors of Mycoplasma pneumoniae.

Authors:  Takashi Shimizu
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.